Ulla Johansson

1.5k total citations
21 papers, 1.1k citations indexed

About

Ulla Johansson is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Ulla Johansson has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in Ulla Johansson's work include Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (5 papers) and HER2/EGFR in Cancer Research (5 papers). Ulla Johansson is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (5 papers) and HER2/EGFR in Cancer Research (5 papers). Ulla Johansson collaborates with scholars based in Sweden, Finland and Iceland. Ulla Johansson's co-authors include Lambert Skoog, Jonas Bergh, Linda S. Lindström, Johan Hartman, Ulla Wilking, Thomas Hatschek, Eva Karlsson, Elisabet Lidbrink, Hemming Johansson and Tommy� Fornander and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Hepatology.

In The Last Decade

Ulla Johansson

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulla Johansson Sweden 16 598 493 272 261 200 21 1.1k
Mila Pinchev Israel 17 534 0.9× 344 0.7× 313 1.2× 185 0.7× 136 0.7× 30 1.0k
Ermelinda De Maio Italy 16 533 0.9× 284 0.6× 425 1.6× 217 0.8× 235 1.2× 30 1.1k
S. Ashley United Kingdom 9 772 1.3× 432 0.9× 234 0.9× 331 1.3× 133 0.7× 12 1.1k
Nigel Sacks United Kingdom 18 521 0.9× 590 1.2× 268 1.0× 466 1.8× 119 0.6× 37 1.2k
Davide Disalvatore Italy 19 684 1.1× 601 1.2× 266 1.0× 124 0.5× 240 1.2× 29 1.3k
M de Latour France 18 431 0.7× 458 0.9× 282 1.0× 168 0.6× 133 0.7× 48 1.2k
Davendra Segara Australia 18 585 1.0× 520 1.1× 660 2.4× 272 1.0× 250 1.3× 27 1.4k
G. Reiner Austria 21 742 1.2× 604 1.2× 272 1.0× 329 1.3× 149 0.7× 46 1.2k
Umberto Veronesi Italy 13 345 0.6× 494 1.0× 177 0.7× 160 0.6× 82 0.4× 37 947
Giorgio Mustacchi Italy 16 662 1.1× 587 1.2× 206 0.8× 219 0.8× 221 1.1× 64 1.0k

Countries citing papers authored by Ulla Johansson

Since Specialization
Citations

This map shows the geographic impact of Ulla Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Johansson more than expected).

Fields of papers citing papers by Ulla Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Johansson. The network helps show where Ulla Johansson may publish in the future.

Co-authorship network of co-authors of Ulla Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Johansson. A scholar is included among the top collaborators of Ulla Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Johansson. Ulla Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Annelie, Laura van ‘t Veer, Gizeh Pérez‐Tenorio, et al.. (2022). Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of Clinical Oncology. 40(35). 4071–4082. 20 indexed citations
2.
Lindström, Linda S., Eva Karlsson, Ulla Wilking, et al.. (2012). Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression. Journal of Clinical Oncology. 30(21). 2601–2608. 370 indexed citations
3.
Fornander, Tommy�, Hemming Johansson, Ulla Johansson, et al.. (2012). Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. European Journal of Cancer. 49(1). 52–59. 99 indexed citations
4.
Sverrisdóttir, Ásgerður, Hemming Johansson, Ulla Johansson, et al.. (2011). Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer. Breast Cancer Research and Treatment. 128(3). 755–763. 21 indexed citations
5.
Linderholm, Barbro, Henrik Hellborg, Ulla Johansson, Lambert Skoog, & Janne Lehtiö. (2010). Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer. Breast Cancer Research and Treatment. 125(2). 457–465. 19 indexed citations
6.
Staaf, Johan, Therese Törngren, Eva Rambech, et al.. (2008). Detection and precise mapping of germline rearrangements inBRCA1, BRCA2, MSH2, andMLH1using zoom-in array comparative genomic hybridization (aCGH). Human Mutation. 29(4). 555–564. 32 indexed citations
7.
He, Qimin, Tommy� Fornander, Hemming Johansson, et al.. (2007). Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.. PubMed. 26(6C). 4753–9. 54 indexed citations
8.
Dalberg, Kristina, Anette Liedberg, Ulla Johansson, & Lars Erik Rutqvist. (2003). Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. European Journal of Surgical Oncology. 29(2). 143–154. 23 indexed citations
9.
Brożek, Izabela, Karin Haraldsson, Therese Sandberg, et al.. (2003). BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland. Human Mutation. 21(5). 553–554. 31 indexed citations
10.
Wirfält, Elisabet, Iréne Mattisson, Bo Gullberg, et al.. (2002). Postmenopausal breast cancer is associated with high intakes of ω6 fatty acids (Sweden). Cancer Causes & Control. 13(10). 883–893. 71 indexed citations
11.
Borg, Åke, Jorma Isola, Jindong Chen, et al.. (2000). Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. International Journal of Cancer. 85(6). 796–796.
12.
Borg, �ke, Jorma Isola, Jindong Chen, et al.. (2000). GermlineBRCA1 andHMLH1 mutations in a family with male and female breast carcinoma. International Journal of Cancer. 85(6). 796–800. 23 indexed citations
13.
14.
15.
Børresen, Anne‐Lise, Tone Ikdahl Andersen, Jórunn E. Eyfjörd, et al.. (1995). TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains. Genes Chromosomes and Cancer. 14(1). 71–75. 142 indexed citations
16.
Johansson, Ulla, John Wahren, & L. S. Eriksson. (1994). Splanchnic and peripheral glucose metabolism in cirrhosis. Journal of Hepatology. 20(6). 760–767. 12 indexed citations
17.
Thörne, Anders, et al.. (1992). Thermogenic response to intravenous nutrition in patients with cirrhosis. Journal of Hepatology. 16(1-2). 145–152. 9 indexed citations
18.
Johansson, Ulla, Thomas Andersson, A. Erik G. Persson, & L. S. Eriksson. (1989). Visual evoked potential — a tool in the diagnosis of hepatic encephalopathy?. Journal of Hepatology. 9(2). 227–233. 24 indexed citations
19.
Johansson, Ulla, et al.. (1986). Rapid purification of monoclonal antibodies by high-performance liquid chromatography. Journal of Chromatography A. 359. 449–460. 43 indexed citations
20.
Johansson, Ulla, et al.. (1986). Monoclonal Antibodies Towards the Fast Inhibitor of Tissue Plasminogen Activator from Human Plasma and Serum. Thrombosis and Haemostasis. 55(3). 383–387. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mila Pinchev Breakdown of academic impact, for papers by Ermelinda De Maio Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by Nigel Sacks Breakdown of academic impact, for papers by Davide Disalvatore Breakdown of academic impact, for papers by M de Latour Breakdown of academic impact, for papers by Davendra Segara Breakdown of academic impact, for papers by G. Reiner Breakdown of academic impact, for papers by Umberto Veronesi Breakdown of academic impact, for papers by Giorgio Mustacchi
Rankless by CCL
2026